Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationScand. J. Rheumatol. 2013, 42 (5):373-8
AbstractTo determine the prevalence and clinical characteristics of psoriatic arthritis mutilans (PAM) in the Nordic countries.
Patients with putative PAM aged ≥ 18 years were recruited. Fifty-nine patients were included after clinical examination.
The prevalence of PAM in the adult Nordic population was estimated to be 3.69 per million inhabitants [95% confidence interval (CI) 2.75-4.63]. The female to male ratio was close to 1:1. The mean age of skin disease onset was 25 years and the mean age of onset of joint disease was 30 years. The onset of skin disease was 2 years earlier among female patients. At inclusion, the mean duration of arthritis was 27 ± 11 years for male patients and 33 ± 11 years for female patients. PAM was most frequently seen in the distal interphalangeal (DIP) joints of the toes, followed by the IP joint of the thumb and the DIP joint of the little finger on the left hand. Female and male patients had similar numbers of painful and swollen joints. Enthesitis was found in 19 patients (32%), while 38 patients (64%) had a history of dactylitis. Twenty-three of these 38 patients (61%) had a history of dactylitis in the same finger/toe as they had PAM. At the time of inclusion, 45% of the patients were found to have clear or almost clear skin.
PAM in the Nordic countries has a low prevalence, with only three to five cases per million inhabitants. The majority of the patients present with mild skin disease.
DescriptionTo access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Scandinavian journal of rheumatology
- Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.
- Authors: Lindqvist U, Gudbjornsson B, Iversen L, Laasonen L, Ejstrup L, Ternowitz T, Ståhle M
- Issue date: 2017 Nov
- Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.
- Authors: Love TJ, Gudbjornsson B, Gudjonsson JE, Valdimarsson H
- Issue date: 2007 Oct
- Hip joint disease in psoriatic arthritis: risk factors and natural history.
- Authors: Michet CJ, Mason TG, Mazlumzadeh M
- Issue date: 2005 Jul
- International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
- Authors: Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, Salvarani C, Thaci D, Toloza SM, Wong MY, Zhou QM, Gladman DD
- Issue date: 2009 Sep 15
- Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis.
- Authors: Huemer C, Malleson PN, Cabral DA, Huemer M, Falger J, Zidek T, Petty RE
- Issue date: 2002 Jul